Related Experiment Video

Updated: Jun 1, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

Australian children are not consuming enough long-chain omega-3 polyunsaturated fatty acids for optimal health

Barbara J Meyer1, Nithin Kolanu

  • 1School of Health Sciences and Metabolic Research Centre, University of Wollongong, Wollongong, New South Wales, Australia. barbara_meyer@uow.edu.au

Nutrition (Burbank, Los Angeles County, Calif.)
|June 11, 2011
PubMed

Insights

Most Australian children do not consume enough long-chain omega-3 polyunsaturated fatty acids (LC ω-3 PUFAs) for optimal health. Intakes did not differ by body weight or physical activity levels in children aged 5-16.

Area of Science:

  • Nutrition Science
  • Pediatric Health
  • Dietary Intake Assessment

Background:

  • Polyunsaturated fatty acids (PUFAs) are essential nutrients for children's growth and development.
  • Adequate intake (AI) and suggested dietary targets (SDTs) for PUFAs exist, but children's actual consumption, particularly of long-chain omega-3 (LC ω-3) PUFAs, is not well-characterized.
  • Understanding PUFA intake is crucial for assessing nutritional status and identifying potential public health concerns.

Purpose of the Study:

  • To quantify polyunsaturated fatty acid (PUFA) intake in Australian children aged 2-16 years.
  • To compare children's PUFA intakes against established adequate intake (AI) levels and adjusted suggested dietary targets (SDTs).
  • To investigate potential differences in PUFA intake based on children's body weight and physical activity levels.

Main Methods:

  • Utilized data from 4486 Australian children aged 2-16 years, sourced from the Australian Social Science Data Archive.
  • Physical activity data were specifically collected for children aged 5-16 years.
  • Analyzed median intakes of linoleic acid, alpha-linolenic acid, and long-chain (LC) omega-3 PUFAs across different age groups.

Main Results:

  • Most children met AI for linoleic and alpha-linolenic acids, but only 50-60% met AI for LC ω-3 PUFAs.
  • A mere 6% of children achieved the adjusted SDT for daily LC ω-3 PUFA intake.
  • No significant differences in LC ω-3 PUFA intake were observed across varying body weight categories or physical activity levels.

Conclusions:

  • The majority of Australian children exhibit insufficient intake of long-chain omega-3 polyunsaturated fatty acids (LC ω-3 PUFAs).
  • Current consumption levels may not support optimal health outcomes for children.
  • Dietary strategies may be needed to improve LC ω-3 PUFA intake in the pediatric population.
Abstract

More Related Videos

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...